What is your approach to differentiating and managing DMARD-induced nodulosis (induced by methotrexate or leflunomide for example) from "de novo" RA nodules in seropositive RA patients?
Answer from: at Academic Institution
Though there are some clinical distinctions that may help to differentiate RA-related nodules from those associated with either methotrexate (MTX) or leflunomide (LEF), one may never be fully certain. RA-related nodules tend to be bigger and fleshy to palpate whereas drug-related nodule formation is...
Comments
at The Center for Rheumatology @Simon, Agree with your descriptions, particularly...
at Uniformed Services University of the Health Sciences (USUHS) @Simon M. Helfgott: That is a very nice, practical...
at UTMB Health Years ago, I had an older patient with RA who deve...
@Simon, Agree with your descriptions, particularly...
@Simon M. Helfgott: That is a very nice, practical...
Years ago, I had an older patient with RA who deve...